[HTML][HTML] Oncogenic KIT induces replication stress and confers cell cycle checkpoint vulnerability in melanoma

CN Njauw, Z Ji, DM Pham, A Simoneau… - Journal of Investigative …, 2022 - Elsevier
Acral and mucosal melanomas arise from sun-protected sites, disproportionately impact
darker-skinned individuals, and exact higher mortality than common types of cutaneous …

Aberrations of KIT, BRAF, NRAS, and PDGFRA in Chinese melanoma patients and their significance: Large, scale analysis of 644 patients.

Y Kong, L Si, J Guo, ZH Chi, CL Cui… - Journal of Clinical …, 2011 - ascopubs.org
8568 Background: Mutations in KIT, BRAF, NRAS and PDGFRA are common in melanoma,
which have not been extensively studied in Asia. We examined these aberrations and …

Sunitinib Therapy for Melanoma Patients with KIT Mutations

DR Minor, M Kashani-Sabet, M Garrido, SJ O'Day… - Clinical cancer …, 2012 - AACR
Purpose: Recent studies have shown activating KIT mutations in melanoma originating from
mucosa, acral, or cumulative sun-damaged skin sites. We aimed to assess the predictive …

The clinical significance of KIT mutations in melanoma: a meta-analysis

HZ Gong, HY Zheng, J Li - Melanoma research, 2018 - journals.lww.com
This study aimed to evaluate the association of KIT mutations with clinicopathologic features
of melanomas using a meta-analysis and to identify differences between Asian and White …

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

CR Antonescu, KJ Busam, TD Francone… - … journal of cancer, 2007 - Wiley Online Library
Activating mutations in either BRAF or NRAS are seen in a significant number of malignant
melanomas, but their incidence appears to be dependent to ultraviolet light exposure. Thus …

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics

SE Woodman, MA Davies - Biochemical pharmacology, 2010 - Elsevier
Despite multiple clinical trials utilizing a spectrum of therapeutic modalities, melanoma
remains a disease with dismal outcomes in patients with advanced disease. However, it is …

Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck

W Guo, G Yin, C Cui, Y Kong, Z Huang… - Acta Oto …, 2022 - Taylor & Francis
Background Mucosal melanoma is the second most common subtype of melanoma in China
and head and neck region is one of the main sites of this disease. Aims/Objectives Analyzed …

[HTML][HTML] Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction

J Tímár, A Ladányi - International journal of molecular sciences, 2022 - mdpi.com
Similar to other malignancies, TCGA network efforts identified the detailed genomic picture
of skin melanoma, laying down the basis of molecular classification. On the other hand …

The mutational landscape of mucosal melanoma

KW Nassar, AC Tan - Seminars in cancer biology, 2020 - Elsevier
Mucosal melanoma is a rare and aggressive subtype of melanoma that has a less favorable
prognosis due to the lack of understanding and identification of oncogenic drivers. Recently …

[HTML][HTML] Multidisciplinary approach and treatment of acral and mucosal melanoma

A Fortuna, T Amaral - Frontiers in Oncology, 2024 - frontiersin.org
Acral and mucosal melanoma are uncommon variants of melanoma. Acral melanoma has
an age-adjusted incidence of approximately 1.8 cases per million individuals per year …